Faslodex treatment to be launched by Wunderman

Wunderman has been chosen to launch a consumer campaign for AstraZeneca’s breast cancer treatment Faslodex. Wunderman will handle DTP relationship marketing efforts aimed at raising awareness in late-stage breast cancer patients, as well as DTC efforts. A print campaign is slated for summer 2007.

You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical